Company / Operating Cash Flow per Share
Perspective Therapeutics, Inc. Operating Cash Flow per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.05
FY2022
5-year range
-$0.10 / -$0.05
FY2018-FY2022
Trend
+25.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has increased for 3 consecutive years, from $-0.10 in FY2019 to $-0.05 in FY2022.
Based on SEC 10-K filings.
-0.05 in FY2022.
Improved from $-0.08 to $-0.05 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Perspective Therapeutics, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2022, operating cash flow per share increased 25.9% year-over-year.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$0.05 | +25.9% |
| FY2021 | -$0.07 | +13.5% |
| FY2020 | -$0.08 | +16.4% |
| FY2019 | -$0.10 | -43.6% |
| FY2018 | -$0.07 | -10.3% |
| FY2017 | -$0.06 | +17.6% |
| FY2016 | -$0.08 | -5.6% |
| FY2015 | -$0.07 | +16.7% |
| FY2014 | -$0.09 | -11.6% |
| FY2013 | -$0.08 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026